BackFredun Pharmaceuticals Limited Overview

Fredun Pharmaceuticals Limited Current Assets

Fredun Pharmaceuticals Limited's current assets is $0.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$0.00

Peer trimmed avg / median

Loading

Fredun Pharmaceuticals Limited Current Assets History

Loading

Fredun Pharmaceuticals Limited vs. peers: Current Assets Comparison

Loading

Fredun Pharmaceuticals Limited Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fredun Pharmaceuticals Limited (FREDUN.BO) FAQ

The latest current assets for FREDUN.BO is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Fredun Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, FREDUN.BO's current assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fredun Pharmaceuticals Limited's operating scale or balance-sheet position.

A current assets figure of $0 for FREDUN.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FREDUN.BO's current assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.